Clotting tests explained: how to read PT, INR, aPTT, fibrinogen and D-dimer

A coagulation panel puts two kinds of test on one report. Prothrombin time (PT), the INR (international normalized ratio), the activated partial thromboplastin time (aPTT), fibrinogen and thrombin time take a tube of your plasma (the liquid part of blood, with the cells spun out) and time how fast it forms a clot, which measures clotting capacity. D-dimer and fibrin degradation products look for fragments of clot your body has already formed and dissolved, which measures clotting activity. No test on the panel can see a clot inside you: a long PT says your blood clots slowly in a tube, and a high D-dimer says clot has been formed and dissolved somewhere, which surgery, pregnancy, infection and age all cause. New to lab reports in general? Start with how to read any lab result.

A coagulation panel mixes two kinds of measurement on one report, and most confusion comes from reading them as one scale. Capacity tests add a trigger chemical to your plasma in the lab and run a stopwatch until a clot forms. They tell you whether your clotting proteins (called clotting factors, made mostly by the liver) are present and working. Activity tests measure debris in your blood. They tell you the body has recently formed fibrin, the mesh that holds a clot together, and then dissolved it.

You do not need to memorize the next diagram. The one thing to take from it: PT and aPTT test two different routes to a clot, so which one is long hints at the cause.

D-dimer antigen is a unique marker of fibrin degradation that is formed by the sequential action of 3 enzymes: thrombin, factor XIIIa, and plasmin.Adam, Key and Greenberg, Blood, 2009 ⁵

In plain terms: D-dimer only appears after a real fibrin clot has formed and then been dissolved.

Every range in the clotting-test table is approximate and varies by lab, because each lab calibrates its own reagents and machines. Read your result against the range printed on your own report; reference ranges explained covers why a flag at the edge of a range often means little on its own.

PT and INR: one measurement, two ways of reporting it

The PT is the raw number of seconds your plasma takes to clot after a tissue factor reagent is added. Three of the factors the PT covers (II, VII and X) need vitamin K to work, so warfarin, which blocks vitamin K, lengthens the PT ⁴. Reagents from different manufacturers give different PT seconds for the same blood, so the INR was introduced to put every lab's PT on one scale. The INR is how warfarin doses are tracked across clinics and home meters, and because it was built for warfarin, a normal INR says nothing reliable about whether apixaban, rivaroxaban or another newer blood thinner is working ². The INR page explains how it is calculated and what each target band is for.

aPTT: the heparin and hemophilia test

The aPTT times the intrinsic and common pathways and usually runs about 25 to 35 seconds, depending on the lab. Hospitals use the aPTT to monitor unfractionated heparin, the IV blood thinner, often checking it several times a day while the dose is being set; the aPTT also lengthens with dabigatran ². Outside hospital, a long aPTT with a normal PT points toward the factors only the aPTT covers: low factor VIII or IX (hemophilia A or B), low factor XI, or von Willebrand disease, which lowers factor VIII. The aPTT also lengthens with lupus anticoagulant, an antibody (see autoimmune) that slows clotting in the tube while raising clot risk in the body. Lupus anticoagulant is the clearest example of why a clotting time measures tube behavior and cannot stand in for your real clot risk.

Fibrinogen and thrombin time

Fibrinogen is the protein thrombin turns into fibrin, and most labs report about 200 to 400 mg/dL as typical. Fibrinogen is also an acute-phase protein (one the liver makes more of during inflammation), so it runs high with infection, inflammation and pregnancy; inflammation markers explained covers that family. Low fibrinogen matters more. It appears with severe liver disease, massive bleeding and disseminated intravascular coagulation (DIC). DIC is a dangerous state in serious illness where clotting runs out of control and uses up factors and platelets. It can lengthen PT and aPTT, lower fibrinogen and platelets, and raise D-dimer all at once. Thrombin time isolates the final step and lengthens with heparin, with dabigatran, and with low or abnormal fibrinogen ².

D-dimer: the activity test on the same report

D-dimer often appears on the same requisition as the clotting times, but D-dimer answers the other question: whether the body has recently formed and dissolved clot. A high D-dimer has many causes besides a clot, including older age, pregnancy, recent surgery, infection and cancer ⁵; infection and inflammation raise it often (see infections). Fibrin degradation products is an older, broader version of the same idea. Cutoffs, age adjustment and the unit trap belong to the D-dimer page. If your D-dimer came back high and you feel well, ask your clinician two things: was it judged against an age-adjusted cutoff ⁷, and does your situation call for a scan, or is the result explained by surgery, pregnancy or infection?

Platelets live on a different test

Platelets are blood cells that form the first plug at a leak, before fibrin reinforces it. A platelet count comes from the complete blood count, which CBC explained walks through, and a coagulation panel does not include it. A person with a low platelet count can bruise and bleed easily while PT, INR and aPTT all read normal, because the capacity tests run on plasma with the platelets removed. Aspirin and clopidogrel work on platelets too, so they do not show up on PT, INR or aPTT. The blood count topic collects the platelet and CBC pages.

Which blood thinners show up on which test

Specialist tests you may see

• Antithrombin III: a natural anticoagulant; low levels, inherited or acquired, raise clot risk and can blunt heparin's effect.
• Protein C: a vitamin K-dependent natural anticoagulant; warfarin lowers it, so results taken on warfarin are hard to read.
• Protein S: protein C's partner; it also falls with warfarin and normally falls in pregnancy.
• Von Willebrand factor: the glue between platelets and a damaged vessel wall; low levels cause the most common inherited bleeding disorder.

Sample problems come first

An unexpectedly long PT or aPTT is often a sample problem before it is a body problem. Coagulation tests use a light-blue-top tube holding 3.2% sodium citrate, a chemical that stops the blood clotting until the lab is ready, and the tube must hold blood and citrate in a 9 to 1 ratio ³. The common ways a clotting sample goes wrong:

• Underfilled tube: too little blood leaves too much citrate, which stretches PT and aPTT ³.
• Very high hematocrit (red cells above about 55% of blood volume): the plasma share is smaller, so the citrate is again in excess and clotting times read long ³.
• Heparin contamination: blood drawn from an IV line or port that was flushed with heparin can show a long aPTT and thrombin time in someone taking no heparin.
• Partly clotted or damaged sample, or a long delay before processing: factors are used up or degrade, and results drift.

When a long clotting time does not fit the person, clinicians usually repeat it from a clean, full tube, often within a few days and drawn from a vein rather than an IV line, before investigating further. If the repeat stays long, a mixing study (the lab mixes your plasma with normal plasma) helps sort a missing factor from an inhibitor such as lupus anticoagulant.

Liver disease: a high INR with a rebalanced system

The liver makes most clotting factors, so liver disease lengthens the PT and raises the INR. The liver also makes the natural anticoagulants, such as protein C and antithrombin, and those fall too. People with cirrhosis therefore reach a rebalanced state, and a high INR in liver disease does not reliably predict bleeding; some patients form dangerous clots instead ¹. The INR is still one input to the MELD score, a number doctors use to grade how advanced liver disease is, including for transplant lists. Liver enzymes explained covers the rest of the liver panel, and the liver topic and fatty liver pages cover the conditions behind it.

How a coagulation panel is ordered and done

• Fasting: not needed for PT, INR, aPTT, fibrinogen or D-dimer.
• Ordering: a coagulation panel is a separate order from the CBC and metabolic panel, drawn into its own citrate tube. Coverage depends on your plan; it is most often ordered for a reason such as surgery, bleeding, liver disease or a blood thinner.
• Before surgery: UK NICE guidance advises against routine clotting tests for otherwise healthy adults having elective surgery, suggests considering them for people with more severe illness who have chronic liver disease, and leaves people on blood thinners to local protocols ⁶. Separately, tell the surgical team about any history of easy bleeding, heavy periods or bleeding after past procedures.
• How often: on warfarin, the clinic sets the INR schedule, and trends beat single readings applies. For a one-off abnormal result in someone not on a blood thinner, a repeat on a clean sample is the usual first step.
• Family history: a family history of clots at a young age or of a bleeding disorder is a reason to ask about the specialist tests above. Those tests are timed carefully, because a fresh clot, pregnancy and warfarin all distort protein C, protein S and antithrombin.

For the whole cluster, including the pages for each marker on the panel, start at the blood clotting topic.

Your results, in contextAdd the lab results you already have, and LifeFrom reads each marker next to the others it moves with, in plain language, with the sources it used.Get started